MarketsStocksNATCOPHARM
NA

NATCO PHARMA

NSE: NATCOPHARMBSE: 524816Healthcare
918.50
-1.71%
NSE · 15-min delayed
Prev Close
₹858.95
Day High
₹939.80
Day Low
₹916.00
Mkt Cap
₹18,185 Cr
P / E
12.8
P / B
2.0
ROE
15.4%
52W High
₹1,226.80
52W Low
₹789.00
Key Metrics
Market Cap
₹18,185 Cr
P / E
12.8
P / B
2.0
ROCE
15.4%
ROE
15.4%
Div Yield
0.5%
Revenue · ₹ Cr
1.9k
FY20
2.1k
FY21
1.9k
FY22
2.7k
FY23
4.0k
FY24
4.4k
FY25
4.1k
FY26
Net Profit · ₹ Cr
458
FY20
442
FY21
170
FY22
715
FY23
1.4k
FY24
1.9k
FY25
1.4k
FY26
EPS · ₹ per share
₹25.3
FY20
₹24.2
FY21
₹9.3
FY22
₹39.2
FY23
₹77.3
FY24
₹105.3
FY25
₹79.2
FY26
P / E Ratio · price ÷ TTM EPS
03365973876114Jun 21Jan 23Oct 24Jun 26
P/E 11.6×Median 19.9×TTM EPS
Q1 2026 snapshot
Sales
₹817 Cr
Operating profit
-
OPM
-
Net profit
₹269 Cr
EPS
₹14.96
Scorecard · 7 axes
Quality
Strong
84/100
Valuation
Strong
12.8×
Growth
Strong
+45.1%
Profitability
Good
15.4%
Performance
Weak
+8.2%
Entry Point
Good
75%
Red Flags
Strong
0 flags
Shareholding Pattern
49.4%Promoter
Promoter49.4%
FII17.4%
DII5.5%
Public27.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue4751,287.31,390.61,463705.4816.9
Net Profit132406480.3517.9151.3269
NPM %27.8%31.5%34.5%35.4%21.4%32.9%
AlertPre-trade